Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 5
2001 2
2002 6
2003 1
2004 1
2005 5
2006 5
2007 1
2008 4
2009 5
2010 3
2011 5
2012 5
2013 6
2014 8
2015 6
2016 12
2017 16
2018 20
2019 22
2020 21
2021 31
2022 20
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Lawrence DP, Groarke JD, Neilan TG. Mahmood SS, et al. Among authors: heinzerling lm. J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19. J Am Coll Cardiol. 2018. PMID: 29567210 Free PMC article.
The skin prick test - European standards.
Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, Durham S, Fokkens W, Gjomarkaj M, Haahtela T, Bom AT, Wöhrl S, Maibach H, Lockey R. Heinzerling L, et al. Clin Transl Allergy. 2013 Feb 1;3(1):3. doi: 10.1186/2045-7022-3-3. Clin Transl Allergy. 2013. PMID: 23369181 Free PMC article.
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, Niederer R, Porsch M, Lichtensteiger C, Kramer R, Erdmann M, Schmitt C, Heinzerling L, Abdou MT, Karbach J, Schadendorf D, Zimmer L, Ugurel S, Klümper N, Hölzel M, Power L, Kreutmair S, Capone M, Madonna G, Cevhertas L, Heider A, Amaral T, Hasan Ali O, Bomze D, Dimitriou F, Diem S, Ascierto PA, Dummer R, Jäger E, Driessen C, Levesque MP, van de Veen W, Joerger M, Früh M, Becher B, Flatz L. Nuñez NG, et al. Among authors: heinzerling l. Med. 2023 Feb 10;4(2):113-129.e7. doi: 10.1016/j.medj.2022.12.007. Epub 2023 Jan 23. Med. 2023. PMID: 36693381 Free article.
Checkpoint Inhibitors.
Heinzerling L, de Toni EN, Schett G, Hundorfean G, Zimmer L. Heinzerling L, et al. Dtsch Arztebl Int. 2019 Feb 22;116(8):119-126. doi: 10.3238/arztebl.2019.0119. Dtsch Arztebl Int. 2019. PMID: 30940340 Free PMC article. Review.
In Reply.
Heinzerling L. Heinzerling L. Dtsch Arztebl Int. 2019 May 17;116(20):363-364. doi: 10.3238/arztebl.2019.0363b. Dtsch Arztebl Int. 2019. PMID: 31288921 Free PMC article. No abstract available.
Insulin allergy.
Heinzerling L. Heinzerling L. Diabet Med. 2013 Aug;30(8):891-2. doi: 10.1111/dme.12233. Diabet Med. 2013. PMID: 23663177 No abstract available.
Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom - ein Update.
Kähler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, Zimmer L, Gutzmer R; für das Komitee „Kutane Nebenwirkungen“ der Arbeitsgemeinschaft Dermatologische Onkologie (ADO). Kähler KC, et al. Among authors: heinzerling l. J Dtsch Dermatol Ges. 2020 Jun;18(6):582-609. doi: 10.1111/ddg.14128_g. J Dtsch Dermatol Ges. 2020. PMID: 32519497 German.
MAPK blockade, toxicities, pathogenesis and management.
Moreira A, Lebbé C, Heinzerling L. Moreira A, et al. Among authors: heinzerling l. Curr Opin Oncol. 2021 Mar 1;33(2):139-145. doi: 10.1097/CCO.0000000000000710. Curr Opin Oncol. 2021. PMID: 33395033 Review.
215 results